Page last updated: 2024-12-09
kakoul
Description
kakoul: from Asarum forbesii Maxim.; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|
| Asarum | genus | A plant genus of the family ARISTOLOCHIACEAE which was used medicinally by North American Indians. The common name of 'snakeroot' is also used for many other plants, including SANICULA; or ARISTOLOCHIA; or Polygala.[MeSH] | Aristolochiaceae | A plant family of the order Aristolochiales subclass Magnoliidae class Magnoliopsida. They are mostly tropical woody vines and a few temperate-zone species. The flowers are 3-parted; some species lack petals while others are large and foul smelling.[MeSH] |
| Asarum forbesii | species | [no description available] | Aristolochiaceae | A plant family of the order Aristolochiales subclass Magnoliidae class Magnoliopsida. They are mostly tropical woody vines and a few temperate-zone species. The flowers are 3-parted; some species lack petals while others are large and foul smelling.[MeSH] |
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 596894 |
| CHEBI ID | 80841 |
| MeSH ID | M0142446 |
Synonyms (24)
| Synonym |
|---|
| 1-propanone, 1-(6-hydroxy-1,3-benzodioxol-5-yl)- |
| 1-(6-hydroxy-1,3-benzodioxol-5-yl)propan-1-one |
| kakoul |
| 18607-90-4 |
| C16982 |
| kakuol |
| CHEBI:80841 |
| 1-propanone,1-(6-hydroxy-1,3-benzodioxol-5-yl)- |
| SLLMHZXMVHNZOR-UHFFFAOYSA-N |
| 2-hydroxy-4,5-methylenedioxypropiophenone |
| 1-(6-hydroxy-1,3-benzodioxol-5-yl)-1-propanone # |
| AC-34390 |
| DTXSID50171850 |
| AKOS030530338 |
| 2'-hydroxy-4',5'-methylenedioxypropiophenone |
| mfcd24717047 |
| Q27151339 |
| HY-N2446 |
| FT-0775497 |
| CS-0022672 |
| MS-23048 |
| A902425 |
| 1-(6-hydroxybenzo[d][1,3]dioxol-5-yl)propan-1-one |
| 1-(6-hydroxy-2h-1,3-benzodioxol-5-yl)propan-1-one |
Drug Classes (1)
| Class | Description |
|---|
| benzodioxoles | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 23.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 23.72 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.16 (4.65) | | Search Engine Demand Index | 23.28 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |